The 3rd European Congress on Hematology and Blood Disorders was successfully held on October 28-29, 2024, at Rome, Italy, gathering an impressive array of global experts, researchers, healthcare professionals, and industry leaders to discuss the latest trends and innovations in women's health. Under the theme, “Hematology Beyond Blood: A Holistic Approach”, the conference provided a platform for comprehensive discussions on cutting-edge advancements, clinical practices, and research breakthroughs in Hematology and Blood Disorders. The event attracted participants from more than 15 countries, including renowned speakers, business delegates, and a vibrant community of students, all dedicated to enhancing Hematology.
The conference commenced with a grand opening ceremony, followed by Keynote Sessions featuring presentations from distinguished speakers who shared their insights on various aspects of Hematology and Blood Disorders. The two-day event included a series of Oral and Poster presentations, where participants presented their latest research findings, fostering lively discussions on critical topics such as Hematology, Leukemia and Blood Cancer, Hemoglobinopathies, and Blood cancer. Esteemed Attendees who graced the stage included:
- Jean Mercier Ythier, Panthéon-Assas University, France
- Natarajan Muthusamy, The Ohio State University, USA
- Zoja Mikniene, Lithuanian University of Health Science, Lithuania
- Rui Wang, Xuzhou Medical University, China
- Tamar Tadmor, Bnai Zion Medical Center and The Bruce Rappoport Faculty of Medicine, Israel
- Franco Musio, University of Virginia School of Medicine, USA
- Abd Al-Roof Higazi, Hadassah-Hebrew University, Israel
- Mohamed Aboulela, Norfolk and Norwich University Hospital, United Kingdom
- Hemshree Desai, Dhanvantari Clinic Ayurvedic Healthcare and Research Centre, India
- Fatma Sajwani, Emirates Health Services, United Arab Emirates
- Francesco Romano, Department of Primary Care, Italy
- Haim Cohen, Haifa University, Israel
- Ning Dong, Moffitt Cancer Center, USA
- Gerardo Santiago Jiménez, Hospital General De Mexico, Mexico
- Riahi Salma, Sahloul University Hospital, Tunisia
- Indre Mickevičiene, Lithuanian University of Health Science (LUHS), Lithuania
- Hiba Ibrahim Khogali, Tawam Hospital, United Arab Emirates
- Donata Mikalauskiene, Vytautas Magnus University (VMU), Lithuania
- Ahmed Mohammed Eid, Emirate Health Care, United Arab Emirates
- Vanjelyn Dior V Roque, St Luke's Medical Center Quezon City, Philippines
- Tomohiro Yamakawa, Obihiro Kosei Hospital, Japan
- Aneta Szudy-Szczyrek, Medical University of Lublin, Poland
- Maïfa Belghoul, University Hospital Sussex NHS Trust, United Kingdom
- Amal Chaabouni, Sahloul University Hospital, Tunisia
- Amardass Dhami, Sheffield Teaching Trust NHS, United Kingdom
- Marte Karen Brattås, Haukeland University Hospital, Norway
- Ali Alsuheel Asseri, King Khalid University, Saudi Arabia
- Muhammad Subhan, Allama Iqbal Medical College Lahore, Pakistan
- Cacoub, Innotech International, France
- Xiangqin Lei, Dianjiang People‘s Hospital of Chong Qing, China
- Mohammad Abohassan, King Khalid University, Saudi Arabia
- Livia Bernardi, Annunziata Hospital Cosenza (Cs), Italy
- Budhika Somawardana, National Cancer Institute, Sri Lanka
- James Heinlein, Fred Hutchinson Cancer Center, USA
- Joo Yup Lee, Catholic Hematology Hospital, South Korea
- Viola Oberhauser, Medical University Vienna, Austria
- Mieke Carlier, Avellana Medical, Belgium
The conference not only provided a platform for exchanging knowledge and experiences but also strengthened collaborations and set the stage for future strategies in the field. The enthusiastic participation of the Organizing Committee, speakers, and attendees significantly contributed to the event's success, making it a memorable gathering.
With the outstanding success of this edition, we are excited to announce our next event, the 4th European Congress on Hematology and Blood Disorders, scheduled for September 29-30, 2025, in Vienna, Austria. We look forward to welcoming you to another enriching experience where we continue to redefine the standards in Hematology and Blood Disorders.
